{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:25:09Z","timestamp":1759159509062,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:00:00Z","timestamp":1712448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:00:00Z","timestamp":1712448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8L0181"],"award-info":[{"award-number":["CMRPG8L0181"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s13304-024-01833-3","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T23:02:55Z","timestamp":1712444575000},"page":"879-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6251-7230","authenticated-orcid":false,"given":"Yi-Hao","family":"Yen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Ying","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hock-Liew","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Chien","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,7]]},"reference":[{"key":"1833_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1833_CR2","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/cancers15041222","volume":"15","author":"YH Yen","year":"2023","unstructured":"Yen YH, Kee KM, Li WF, Liu YW, Wang CC, Hu TH et al (2023) Stationary trend in elevated serum alpha-fetoprotein level in hepatocellular carcinoma patients. Cancers (Basel) 15:1222. https:\/\/doi.org\/10.3390\/cancers15041222","journal-title":"Cancers (Basel)"},{"key":"1833_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/hep.28123","volume":"62","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M et al (2015) Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology 62:1723\u20131730. https:\/\/doi.org\/10.1002\/hep.28123","journal-title":"Hepatology"},{"key":"1833_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cgh.2022.03.010","volume":"21","author":"MA Karim","year":"2023","unstructured":"Karim MA, Singal AG, Kum HC, Lee YT, Park S, Rich NE et al (2023) Clinical characteristics and outcomes of nonalcoholic fatty liver disease-associated hepatocellular carcinoma in the United States. Clin Gastroenterol Hepatol 21:670-680.e18. https:\/\/doi.org\/10.1016\/j.cgh.2022.03.010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1833_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2015.01.024","volume":"63","author":"L Vigan\u00f2","year":"2015","unstructured":"Vigan\u00f2 L, Conci S, Cescon M, Fava C, Capelli P, D\u2019Errico A et al (2015) Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: a multicenter matched analysis with HCV-related HCC. J Hepatol 63:93\u2013101. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.024","journal-title":"J Hepatol"},{"key":"1833_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/apt.14261","volume":"46","author":"R Pais","year":"2017","unstructured":"Pais R, Fartoux L, Goumard C, Scatton O, Wendum D, Rosmorduc O, Ratziu V (2017) Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Aliment Pharmacol Ther 46:856\u2013863. https:\/\/doi.org\/10.1111\/apt.14261","journal-title":"Aliment Pharmacol Ther"},{"key":"1833_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jamcollsurg.2019.07.012","volume":"229","author":"YX Koh","year":"2019","unstructured":"Koh YX, Tan HJ, Liew YX, Syn N, Teo JY, Lee SY et al (2019) Liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma. J Am Coll Surg 229:467-478.e1. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2019.07.012","journal-title":"J Am Coll Surg"},{"key":"1833_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/oncolo\/oyac251","volume":"28","author":"S Pal Chaudhary","year":"2023","unstructured":"Pal Chaudhary S, Reyes S, Chase ML, Govindan A, Zhao L, Luther J et al (2023) Resection of NAFLD\/NASH-related hepatocellular carcinoma (HCC): clinical features and outcomes compared with HCC due to other etiologies. Oncologist 28:341\u2013350. https:\/\/doi.org\/10.1093\/oncolo\/oyac251","journal-title":"Oncologist"},{"key":"1833_CR9","doi-asserted-by":"publisher","unstructured":"Conci S, Cipriani F, Donadon M, Marchitelli I, Ardito F, Famularo S, et al, He.RC.O.Le.S Group (2022) Hepatectomy for metabolic associated fatty liver disease (MAFLD) related HCC: propensity case-matched analysis with viral- and alcohol-related HCC. Eur J Surg Oncol 48:103\u2013112. https:\/\/doi.org\/10.1016\/j.ejso.2021.07.015.","DOI":"10.1016\/j.ejso.2021.07.015"},{"key":"1833_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cgh.2019.08.011","volume":"1","author":"S Grimaudo","year":"2020","unstructured":"Grimaudo S, Pipitone RM, Pennisi G, Celsa C, Camm\u00e0 C, Di Marco V et al (2020) Association between PNPLA3 rs738409 C>G variant and liver-related outcomes in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 1:935-944.e3. https:\/\/doi.org\/10.1016\/j.cgh.2019.08.011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1833_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","volume":"76","author":"TC Yip","year":"2022","unstructured":"Yip TC, Lee HW, Chan WK, Wong GL, Wong VW (2022) Asian perspective on NAFLD-associated HCC. J Hepatol 76:726\u2013734. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.024","journal-title":"J Hepatol"},{"key":"1833_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D et al (2023) AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77:1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"1833_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK et al (2017) The Eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 67:93\u201399. https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"1833_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/hep.23315","volume":"51","author":"JE Everhart","year":"2010","unstructured":"Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE et al (2010) Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 51:585\u2013594. https:\/\/doi.org\/10.1002\/hep.23315","journal-title":"Hepatology"},{"key":"1833_CR15","unstructured":"Bryer J (2017) TriMatch: propensity score matching of non-binary treatments. Available online at: https:\/\/cran.r-project.org\/web\/packages\/TriMatch\/"},{"key":"1833_CR16","doi-asserted-by":"publisher","first-page":"20f13681","DOI":"10.4088\/JCP.20f13681","volume":"81","author":"C Andrade","year":"2020","unstructured":"Andrade C (2020) Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry 81:20f13681. https:\/\/doi.org\/10.4088\/JCP.20f13681","journal-title":"J Clin Psychiatry"},{"key":"1833_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864\u2013871. https:\/\/doi.org\/10.1053\/he.2000.5852","journal-title":"Hepatology"},{"key":"1833_CR18","unstructured":"Doyle DJ, Hendrix JM, Garmon EH (2024) American society of anesthesiologists classification. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, 17 Aug 2023"},{"issue":"2","key":"1833_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"1833_CR20","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312.e1","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C et al (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158:1999\u20132014. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312.e1","journal-title":"Gastroenterology"},{"key":"1833_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jhep.2004.02.013","volume":"40","author":"SH Caldwell","year":"2004","unstructured":"Caldwell SH, Crespo DM (2004) The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 40:578\u2013584. https:\/\/doi.org\/10.1016\/j.jhep.2004.02.013","journal-title":"J Hepatol"},{"key":"1833_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jhep.2004.02.013","volume":"99","author":"JD Browning","year":"2004","unstructured":"Browning JD, Kumar KS, Saboorian MH, Thiele DL (2004) Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 99:292\u2013298. https:\/\/doi.org\/10.1016\/j.jhep.2004.02.013","journal-title":"Am J Gastroenterol"},{"key":"1833_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/infdis\/jiaa739","volume":"224","author":"J Li","year":"2021","unstructured":"Li J, Yang HI, Yeh ML, Le MH, Le AK, Yeo YH et al (2021) Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B. J Infect Dis 224:294\u2013302. https:\/\/doi.org\/10.1093\/infdis\/jiaa739","journal-title":"J Infect Dis"},{"key":"1833_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0165-1110(96)90005-6","volume":"366","author":"HM Shen","year":"1996","unstructured":"Shen HM, Ong CN (1996) Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat Res 366:23\u201344. https:\/\/doi.org\/10.1016\/s0165-1110(96)90005-6","journal-title":"Mutat Res"},{"key":"1833_CR25","doi-asserted-by":"publisher","first-page":"eaan6446","DOI":"10.1126\/scitranslmed.aan6446","volume":"9","author":"AWT Ng","year":"2017","unstructured":"Ng AWT, Poon SL, Huang MN, Lim JQ, Boot A, Yu W et al (2017) Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med 9:eaan6446. https:\/\/doi.org\/10.1126\/scitranslmed.aan6446","journal-title":"Sci Transl Med"},{"key":"1833_CR26","volume-title":"Mycotoxin control in low- and middle-income countries","author":"CP Wild","year":"2015","unstructured":"Wild CP, Miller JD, Groopman JD (2015) Mycotoxin control in low- and middle-income countries. International Agency for Research on Cancer, Lyon"},{"key":"1833_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2009.02.057","volume":"286","author":"D Gouas","year":"2009","unstructured":"Gouas D, Shi H, Hainaut P (2009) The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy. Cancer Lett 286:29\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2009.02.057","journal-title":"Cancer Lett"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-024-01833-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:22:32Z","timestamp":1716823352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-024-01833-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1007\/s13304-024-01833-3","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"type":"print","value":"2038-131X"},{"type":"electronic","value":"2038-3312"}],"subject":[],"published":{"date-parts":[[2024,4,7]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose for all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of Kaohsiung Chang Gung Memorial Hospital approved this study (Reference number: 202000398B0) and waived the need for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The Institutional Review Board of Kaohsiung Chang Gung Memorial Hospital approved this study (Reference number: 202000398B0) and waived the need for informed consent due to the retrospective nature of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights, informed consent"}}]}}